Stent Price Cut

The change could have financial implications for leading drug manufacturers like Abbott Laboratories, Bayer AG, and GlaxoSmithKline, among others

In a letter to the govt, regulator asks for inclusion of more devices 'as soon as possible'

AHA report believes NPPA's decision would also benefit domestic stent makers